Synthetic mucus barrier arrays as a nanoparticle formulation screening platform
RSC Pharmaceutics · 2024 · 1 (2) · 218-226
DOI: 10.1039/d3pm00057e ↗At a glance
Journal article in RSC Pharmaceutics, 2024. Written by Harry Zou and 5 co-authors. Institution: Fischell Department of Bioengineering, University of Maryland College Park MD 20742 USA gaduncan@umd.edu. Cited 16 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC 3.0). Funded by: NHLBI NIH HHS, Burroughs Wellcome Fund, Cystic Fibrosis Foundation.
Abstract (original language)
Synthetic mucus barrier arrays are developed as a high-throughput screening platform for nanoparticle drug delivery applications.
Authors and institutions
- Fischell Department of Bioengineering, University of Maryland College Park MD 20742 USA gaduncan@umd.edu.
ORCID profiles: Allison Boboltz, Gregg A Duncan
Funding
- NHLBI NIH HHS
- Burroughs Wellcome Fund
- Cystic Fibrosis Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
- Division of Chemical, Bioengineering, Environmental, and Transport Systems
Cite
APA
Zou, H., Boboltz, A., Cheema, Y., Song, D., Cahn, D., & Duncan, G. A. (2024). Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC Pharmaceutics, 1(2), 218-226. https://doi.org/10.1039/d3pm00057e
Vancouver
Zou H, Boboltz A, Cheema Y, Song D, Cahn D, Duncan GA. Synthetic mucus barrier arrays as a nanoparticle formulation screening platform. RSC Pharmaceutics. 2024;1(2):218-226. doi:10.1039/d3pm00057e
BibTeX
@article{Zou2024,
author = {Zou, Harry and Boboltz, Allison and Cheema, Yahya and Song, Daniel and Cahn, Devorah and Duncan, Gregg A},
title = {Synthetic mucus barrier arrays as a nanoparticle formulation screening platform},
journal = {RSC Pharmaceutics},
year = {2024},
volume = {1},
number = {2},
pages = {218--226},
doi = {10.1039/d3pm00057e}
}
EUVIMED